Literature DB >> 19390510

D3 dopamine receptor regulation of ETB receptors in renal proximal tubule cells from WKY and SHRs.

Changqing Yu1, Zhiwei Yang, Hongmei Ren, Yie Zhang, Yu Han, Duofen He, Quansheng Lu, Xiaoyan Wang, Xukai Wang, Chengming Yang, Laureano D Asico, Ulrich Hopfer, Gilbert M Eisner, Pedro A Jose, Chunyu Zeng.   

Abstract

BACKGROUND: The dopaminergic and endothelin systems, by regulating sodium transport in the renal proximal tubule (RPT), participate in the control of blood pressure. The D(3) and ETB receptors are expressed in RPTs, and D(3) receptor function in RPTs is impaired in spontaneously hypertensive rats (SHRs). Therefore, we tested the hypothesis that D(3) receptors can regulate ETB receptors, and that D(3) receptor regulation of ETB receptors in RPTs is impaired in SHRs.
METHODS: ETB receptor expression in RPT cells was measured by immunoblotting and reverse transcriptase-PCR and ETB receptor function by measuring Na(+)-K(+) ATPase activity. D(3)/ETB receptor interaction was studied by co-immunoprecipitation.
RESULTS: In Wistar-Kyoto (WKY) RPT cells, the D(3) receptor agonist, PD128907, increased ETB receptor protein expression, effects that were blocked by removal of calcium in the culture medium. The stimulatory effect of D(3) on ETB receptor mRNA and protein expression was also blocked by nicardipine. In contrast, in SHR RPT cells, PD128907 decreased ETB receptor expression. Basal D(3)/ETB receptor co-immunoprecipitation was three times greater in WKY than in SHRs. The absolute amount of D(3)/ETB receptor co-immunoprecipitation induced by a D(3) receptor agonist was also greater in WKY than in SHRs. Stimulation of ETB receptors decreased Na(+)-K(+) ATPase activity in WKY but not in SHR cells. Pretreatment with PD128907 augmented the inhibitory effect of BQ3020 on Na(+)-K(+) ATPase activity in WKY but not in SHR cells.
CONCLUSIONS: D(3) receptors regulate ETB receptors by physical receptor interaction and govern receptor expression and function. D(3) receptor regulation of ETB receptors is aberrant in RPT cells from SHRs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390510      PMCID: PMC3705568          DOI: 10.1038/ajh.2009.80

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  46 in total

1.  Endothelin-1 chronically inhibits Na/H exchanger-3 in ET(B)-overexpressing OKP cells.

Authors:  T S Chu; K D Wu; M S Wu; B S Hsieh
Journal:  Biochem Biophys Res Commun       Date:  2000-05-19       Impact factor: 3.575

Review 2.  Renal tubular effects of endothelin-B receptor signaling: its role in cardiovascular homeostasis and extracellular volume regulation.

Authors:  T Ohuchi; M Yanagisawa; C E Gariepy
Journal:  Curr Opin Nephrol Hypertens       Date:  2000-07       Impact factor: 2.894

3.  Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice.

Authors:  X X Li; M Bek; L D Asico; Z Yang; D K Grandy; D S Goldstein; M Rubinstein; G M Eisner; P A Jose
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

4.  Expression of the dopamine D3 receptor protein in the rat kidney.

Authors:  D P O'Connell; C J Vaughan; A M Aherne; S J Botkin; Z Q Wang; R A Felder; R M Carey
Journal:  Hypertension       Date:  1998-11       Impact factor: 10.190

5.  Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats.

Authors:  D L Lange; J R Haywood; C Hinojosa-Laborde
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

6.  Impaired renal D(1)-like and D(2)-like dopamine receptor interaction in the spontaneously hypertensive rat.

Authors:  C A Ladines; C Zeng; L D Asico; X Sun; F Pocchiari; C Semeraro; J Pisegna; S Wank; I Yamaguchi; G M Eisner; P A Jose
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-10       Impact factor: 3.619

7.  Impaired sodium excretion, decreased glomerular filtration rate and elevated blood pressure in endothelin receptor type B deficient rats.

Authors:  B Hocher; C Dembowski; T Slowinski; S T Friese; A Schwarz; A L Siren; H H Neumayer; C Thöne-Reineke; C Bauer; B Nafz; H Ehrenreich
Journal:  J Mol Med (Berl)       Date:  2001       Impact factor: 4.599

8.  Endothelin inhibits thick ascending limb chloride flux via ET(B) receptor-mediated NO release.

Authors:  C F Plato; D M Pollock; J L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2000-08

9.  Differential expression of adenylyl cyclases in the rat nephron.

Authors:  M J Bek; S Zheng; J Xu; I Yamaguchi; L D Asico; X G Sun; P A Jose
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

10.  Dopamine D3 receptor activation modulates renal function in anesthetized rats.

Authors:  G Luippold; E Küster; T O Joos; B Mühlbauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1998-12       Impact factor: 3.000

View more
  21 in total

1.  Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney.

Authors:  Ye Zhang; Chunjiang Fu; Laureano D Asico; Van Anthony M Villar; Hongmei Ren; Duofen He; Zhen Wang; Jian Yang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2011-06-02       Impact factor: 3.872

Review 2.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 3.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

Review 4.  Endothelin receptors: what's new and what do we need to know?

Authors:  Stephanie W Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

5.  Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs.

Authors:  Nathan M Appel; Shou-Hua Li; Tyson H Holmes; Jane B Acri
Journal:  J Pharmacol Exp Ther       Date:  2015-07-15       Impact factor: 4.030

Review 6.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 7.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

Review 8.  Noncoding RNAs in the Regulatory Network of Hypertension.

Authors:  Gengze Wu; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 9.  Genetics of salt-sensitive hypertension.

Authors:  Hironobu Sanada; John E Jones; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 10.  Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis.

Authors:  Zheng-He Yu; Hai-Yin Jiang; Li Shao; Yuan-Yue Zhou; Hai-Yan Shi; Bing Ruan
Journal:  Br J Clin Pharmacol       Date:  2016-05-23       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.